Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

This study has been completed.

Study NCT00053300 Information provided by Case Comprehensive Cancer Center

First Received: January 27, 2003 Last Updated: June 9, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	April 2010
Primary Completion Date:	November 2005 (Final data collection date for primary outcome measure)

Publications:

Cooney MM, Subbiah S, Chapman R, et al.: Phase II trial of maintenance daily oral thalidomide in patients with extensive-stage small cell lung cancer (ES-SCLC) in remission. [Abstract] J Clin Oncol 23 (Suppl 16): A-7166, 661s, 2005.